LifeMD (LFMD) Share-based Compensation (2012 - 2025)

LifeMD (LFMD) has reported Share-based Compensation for 14 consecutive years, with $2.7 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Share-based Compensation fell 14.49% year-over-year to $2.7 million; the trailing twelve-month figure through Dec 2025 stood at $11.2 million (down 5.71% YoY), and the FY2025 full-year result was $10.5 million, down 14.21% from the prior year.
• Share-based Compensation fell to $2.7 million in Q4 2025 per LFMD's latest filing, from $8.2 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $8.2 million in Q1 2025 and bottomed at $1.8 million in Q4 2022.
• Historically, Share-based Compensation has averaged $4.9 million across 5 years, with a median of $4.3 million in 2021.
• The widest YoY moves for Share-based Compensation: up 132.64% in 2021, down 82.34% in 2021.
• Over 5 years, Share-based Compensation stood at $4.1 million in 2021, then sank by 55.12% to $1.8 million in 2022, then soared by 98.71% to $3.6 million in 2023, then retreated by 14.83% to $3.1 million in 2024, then declined by 14.49% to $2.7 million in 2025.
• According to Business Quant data, Share-based Compensation over the past three periods registered $2.7 million, $8.2 million, and $8.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.